JOA - 2026-11-01 - Journal Article; Multicenter Study
Implant Survivorship and Functional Recovery Utilizing a Modern Knee Fusion Nail Spacer for Periprosthetic Joint Infection.
Naylor BH, Bradham A, Shah RP, Schwab JM, McConnell MJ, Dash AS, Daftari A, Minter JE
Topics
Key Takeaway
A modular knee fusion nail spacer achieved successful TKA reimplantation in 60.3% of patients with chronic PJI, with a 16% reinfection rate and zero mechanical implant failures at mean 22.4-month follow-up.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This retrospective multicenter study evaluated outcomes of a modular knee fusion nail spacer (FNS) as a static spacer construct in 63 patients with chronic PJI undergoing two-stage revision TKA between 2017 and 2023. Successful reimplantation was achieved in 60.3%; 28.6% retained the FNS as a definitive construct and 9.5% required unplanned reoperation. Reinfection occurred in 16%, radiographic loosening in 9.4%, periprosthetic fracture in 4.8%, and post-reimplantation ROM averaged 87.6° flexion with no mechanical implant failures.
Key Limitation
The 60.3% reimplantation rate conflates patients who were medically unfit, chose retention, or failed infection eradication, making it impossible to isolate true infection control efficacy of the FNS construct.
Original Abstract
BACKGROUND
Traditional indications for static spacers include substantial bone loss, ligamentous insufficiency, extensor mechanism dysfunction, or severe soft-tissue compromise. However, conventional designs are associated with high complication rates and morbidity. A knee fusion nail spacer (FNS) construct combines mechanical stability with targeted antibiotic delivery. This study aimed to (1) describe outcomes of FNS use in terms of total knee arthroplasty (TKA) reimplantation, infection eradication, and limb salvage; (2) determine FNS survivorship with reinfection as the endpoint; and (3) report complications and functional recovery.
METHODS
This retrospective multicenter study reviewed chart and radiographic data from 63 patients treated between 2017 and 2023. The primary outcome was implant survivorship with reimplantation as the endpoint. Secondary outcomes included spacer- or wound-related complications, venous thromboembolisms, acute kidney injuries, functional recovery, and reinfections. Kaplan-Meier analyses assessed implant survivorship, and univariate Cox regression identified predictors of implant failure.
RESULTS
Successful reimplantation was achieved in 60.3% of patients. Of the remainder, 28.6% retained their FNS and 9.5% underwent unplanned reoperations. Reinfection was identified in 16% with three with FNS and seven following reimplantation. The mean follow-up period was 22.4 months (range, zero to 84). There were no cases of implant mechanical failure. Radiographic implant loosening was observed in 9.4% of patients, and three (4.8%) patients experienced periprosthetic fracture. The mean knee range of motion post-reimplantation was 3.6 degrees of extension (range, -5 to 48) and 87.6 degrees of flexion (range, 10 to 125).
CONCLUSIONS
The modular FNS demonstrates favorable survivorship, acceptable reinfection rates, and low mechanical complication rates in patients who have chronic knee PJI, many of whom present with severe bone loss, soft-tissue compromise, and instability. The FNS offers a safe and durable option for infection control and limb salvage in a population with limited reconstructive alternatives.